Short-term prognostic factors of rituximab combined with glucocorticoids in the treatment of pemphigus: A multicenter retrospective study

Supplementary Table 1: This table compares the baseline clinical and laboratory characteristics between pemphigus patients who achieved complete remission on minimal therapy (CR mini) and those who did not. Supplementary Table 2: This table details the baseline characteristic differences between pemphigus patients who experienced short-term relapse after rituximab treatment and those who remained in remission. Supplementary Table 3: This table presents the univariate logistic regression analysis of potential baseline factors influencing the achievement of CR mini in rituximab-treated pemphigus patients. Supplementary Table 4: This table provides the univariate logistic regression results evaluating potential baseline risk factors for short-term relapse in pemphigus patients following rituximab therapy.